Jeffrey Levine
CFO | Seeking a just world I Author

How Big Data & AI can fight the COVID-19 Crisis

With Israel reporting sustained increases in new coronavirus cases, there is fear about the pandemic’s resurgence on the rise and the knock-on effect of freedom of movement and on the Economy. That is placing renewed pressure on the key elements in the healthcare system, not enough beds, and the pressure to find solutions for early detection, containment, diagnosis, and vaccine development. And of course, National Lockdowns and the severe damage to people’s Livelihoods.

So, what can be done to improve the situation? Artificial intelligence (AI) and Big data have the potential to bring an arsenal of important weapons to this fight. But the reviews are mixed on how effectively healthcare has used AI in the past. Many experts hope that the current crisis will change that.

The use of Big Data in Medicine is not new and we have an interesting case of Big Data , statistics story from Florence Nightingale (1820 -1910) who was an English social reformer, statistician, and the founder of modern nursing. Nightingale came to prominence while serving as a manager and trainer of nurses during the Crimean War, in which she organised to care for wounded soldiers

She was a pioneer in data visualization with the use of infographics, effectively using graphical presentations of statistical data. This helped saved Lives.

Although she was a manager of Nurses, she was not a Nurse. Hence, the idea that non-medical knowledge can be instrumental in the fight against Covid19.

JLM Bio City  is hosting an impressive online Event and Panel discussing the intersection of Big Data and AI with Medicine to fight the COVID-19 Crisis on Sept 23rd.

Some of the issues that will be addressed:

Given the debates in Israel regarding the capacity of the health system and the decision to shut down the economy, is this the right timing to use AI-driven decision making?

What data is currently missing to better understand/tackle COVID-19 using AI?

Can we train an AI questionnaire of symptoms and use it instead of physical PCR tests for the diagnosis of COVID-19?

In this urgency to roll out novel AI solutions in this current crisis, are there dangers of corner-cutting with some of the intrinsic issues of the field such as biases, and the amount/quality of training data?

Some critics are saying that AI research is still a form of supply trying to find demand, rather than the other way around. Is that fair in this current situation?

How to avoid rushing through unproven solutions? How to get the balance right between risk and rapidity?

Light-touch regulation has been helpful in this current climate – but ethical standards need to be maintained. Have they got the balance, right?

What is the panelists’ opinion on the regulatory challenges presented by AI/ML solutions, such as whether they should be classified as medical devices or services, and what evidence should be required to permit marketing for AI/ML-based software as a medical device?

There is a lot of important research work from academia in the AI/ML field who are analyzing the data streams and finding patterns, for example, the influence of temperature on the number of infectious cases. Is this information being successfully exposed to the relevant people in public health who are managing the crisis?

One of the main issues governments are tackling is the balance between keeping the economy afloat while controlling the number of cases. How can ML/AI help to get this balance right?

Has AI reached the level of confidence when it can be allowed to make life-or-death decisions in the fight against COVID?

Data and COVID – are patients’ rights being protected?

Could information such as COVID indices of high risk be used in the wrong way for example, by insurance companies?

Can we train an AI questionnaire of symptoms and use it instead of physical PCR tests for the diagnosis of COVID-19?

Joint JLM-BioCity – IGT\Cloud Online Conference on “How Big Data & AI Can Fight the COVID-19 Crisis”

Time: Wednesday, September 23rd at 20:00 – 21:00 (Israel Time) 13:00 – 14:00 EDT

To sign up to the event

The fight against the novel coronavirus is entering a new phase, as people worldwide begin to resume normal life alongside an invisible enemy. To help win this battle, experts are turning to a potentially potent weapon: big data.

At this event, the panelists will discuss the role of AI and big data in the fight against the coronavirus crisis

Invited speakers are:

Prof Paul Rothman, Dean, Johns Hopkins University School of Medicine; CEO, Johns Hopkins Medicine

Prof Itamar Grotto, Associate Director-General, Israel Ministry of Health

Dr Kira Radinsky, ChairWoman & Chief Technology Officer at Diagnostic Robotics

Dr. Tal Tova PatalonMD, LL. B, MBA, Director, Institute for Health Research and Innovation KSM – Maccabi Healthcare Services

JLM-BioCity has teamed up with the IGTCloud Israel Cloud Computing Association to organize this event which is sponsored by the Azrieli College of Engineering, AtoBe and Bio-Jerusalem.

JLM-BioCity is the largest forum of bio entrepreneurs (+3000 followers) , investors, and professionals in Jerusalem, working to accelerate medical and bio innovation in the City.

The IGTCloud is a leading high-tech technology community (+7,000 members) of top industry companies, start-ups, ISVs, VCs and academia, focused on Cloud, BIG Data, AI & Data Science-based technologies and solutions.

Invitation to get involved

I have recently got involved as a volunteer for JLM-BioCity.

JLM-BioCity is a non-profit organization focused on developing and excelling in Jerusalem’s bio-community.

JLM-Bio City invites you, researcher, professional, investor, and executive to become part of our vision, in building Jerusalem’s Biomed eco-system.

If you want your company featured in their blogs, news releases, please contact info@ Over the last few years, JLM BioCity has published over 250 news releases covering over 100 Start-ups, Innovations, and Companies with a connection to Jerusalem.

Below is a map of the Jerusalem Bio / MedTech Scene highlighting Jerusalem as a  major player

Here are some examples of some of the previous events

All images and photos are sourced and are used with the permission of Jlm-Bio City

About the Author
Jeffrey is a CFO | Seeking a just world I Author -living in Jerusalem. He is a young grandfather who has five kids and seven grandchildren. Jeffrey is promoting a vision for a better and fairer world through and is the author of Upgrading ESG - How Business can thrive in the age of Sustainability
Related Topics
Related Posts